Camp4 Therapeutics (CAMP) Capital Expenditures (2023 - 2025)

Camp4 Therapeutics has disclosed Capital Expenditures across 3 years of filings, most recently posting $279000.0 for Q2 2025.

• Capital Expenditures for Q2 2025 came in at $279000.0, up 71.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $279000.0 (up 1960.0% YoY), and the FY2025 annual result was $279000.0, changed N/A from the prior year.
• Capital Expenditures came in at $279000.0 for Q2 2025 at Camp4 Therapeutics, up from -$178000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $279000.0 in Q2 2025 to a low of -$178000.0 in Q4 2024.
• The 3-year median for Capital Expenditures is $15000.0 (2024), against an average of $47000.0.
• Across the five-year window, Capital Expenditures plunged 304.55% in 2024 and soared 71.17% in 2025, its largest moves.
• Camp4 Therapeutics' Capital Expenditures stood at -$44000.0 in 2023, then slumped by 304.55% to -$178000.0 in 2024, then soared by 256.74% to $279000.0 in 2025.
• The last three Capital Expenditures figures came in at $279000.0 (Q2 2025), -$178000.0 (Q4 2024), and $163000.0 (Q2 2024), per Business Quant data.